Related Experiment Video

Updated: Apr 18, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

347

Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53

Lizhong Wang1, Runhua Liu1, Peiying Ye2

  • 1Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

Nature Communications
|January 21, 2015
PubMed

Insights

CD24 overexpression promotes cancer by inhibiting p53. Silencing CD24 in prostate cancer hinders tumor growth and metastasis by restoring p53 function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • CD24 is overexpressed in human cancers.
  • TP53 is a frequently mutated tumor suppressor gene.

Purpose of the Study:

  • Investigate the role of CD24 in prostate cancer progression.
  • Elucidate the mechanism by which CD24 influences TP53 tumor suppressor activity.

Main Methods:

  • Targeted mutation and shRNA silencing of CD24 in prostate cancer models.
  • Analysis of ARF, NPM, MDM2, p53, and p21/CDKN1A protein levels.
  • In silico analysis of TP53 mutation rates in relation to CD24 mRNA levels in patient samples.

Main Results:

  • CD24 silencing reduced prostate cancer growth, progression, and metastasis.
  • CD24 was found to competitively inhibit ARF binding to NPM, leading to decreased p53 levels.
  • CD24 silencing prevented p53 inactivation by somatic mutations and viral oncogenes.
  • Higher CD24 mRNA levels correlated with increased TP53 mutation rates in glioma and prostate cancer.

Conclusions:

  • CD24 plays a significant role in promoting prostate cancer by functionally inactivating the ARF-MDM2-p53 pathway.
  • CD24 silencing represents a potential therapeutic strategy for prostate cancer.
  • The study reveals a novel cellular context for TP53 inactivation.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

17.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K